About Cytox
Cytox is a company based in Oxford (United Kingdom) founded in 2007.. Cytox has raised $12.13 million across 8 funding rounds from investors including Gov.uk, Maven Capital Partners and Future Planet Capital Regional. The company has 12 employees as of January 31, 2021. Cytox operates in a competitive market with competitors including Strand Life Sciences, Invitae, Genome Medical, Myriad Genetics and Fulgent Genetics, among others.
- Headquarter Oxford, United Kingdom
- Employees 12 as on 31 Jan, 2021
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cytox Limited
- Date of Incorporation 09 Jun, 2004
- Jurisdiction MANCHESTER
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$12.13 M (USD)
in 8 rounds
-
Latest Funding Round
-
Investors
Gov.uk
& 14 more
-
Employee Count
12
as on Jan 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Cytox
Cytox has successfully raised a total of $12.13M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Last Round
-
First Round
First Round
(24 Jun 2009)
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2019 | Amount | Series B - Cytox | Valuation | Maven Capital Partners |
|
| May, 2019 | Amount | Grant - Cytox | Valuation |
investors |
|
| Feb, 2019 | Amount | Grant - Cytox | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cytox
Cytox has secured backing from 15 investors, including venture fund and institutional investors. Prominent investors backing the company include Gov.uk, Maven Capital Partners and Future Planet Capital Regional. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are targeted for private equity investments.
|
Founded Year | Domain | Location | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Investment solutions are provided by Catapult Ventures for growth.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cytox
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cytox
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cytox Comparisons
Competitors of Cytox
Cytox operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Strand Life Sciences, Invitae, Genome Medical, Myriad Genetics and Fulgent Genetics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| domain | founded_year | HQ Location |
Home-based genetic tests for detecting diseases are provided to individuals.
|
|
| domain | founded_year | HQ Location |
Genomic testing services are provided clinically and directly to consumers.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostics and personalized medicine for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Provider of genetic testing services for carrier screening cardiovascular diseases, epilepsy and cancer
|
|
| domain | founded_year | HQ Location |
High-throughput gene sequencing platform is developed for clinical diagnostics.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cytox
Frequently Asked Questions about Cytox
When was Cytox founded?
Cytox was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Where is Cytox located?
Cytox is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Is Cytox a funded company?
Cytox is a funded company, having raised a total of $12.13M across 8 funding rounds to date. The company's 1st funding round was a Grant of $65.45K, raised on Jun 24, 2009.
How many employees does Cytox have?
As of Jan 31, 2021, the latest employee count at Cytox is 12.
What does Cytox do?
Cytox was founded in 2007 in Oxford, United Kingdom, within the biotechnology sector focused on diagnostics. SNP targets in the mTOR pathway are investigated to predict and diagnose mild cognitive impairment, recognized as an early stage of dementia and Alzheimers disease. Diagnostic approaches are provided through two products, genoSCORE LAB and genoTOR, which employ blood and saliva samples for risk assessment.
Who are the top competitors of Cytox?
Cytox's top competitors include Strand Life Sciences, Fulgent Genetics and Centogene.
Who are Cytox's investors?
Cytox has 15 investors. Key investors include Gov.uk, Maven Capital Partners, Future Planet Capital Regional, European Union, and Oxford University Innovation.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.